CRYOSURGERY IN THE TREATMENT OF PATIENTS WITH BONE TUMORS

2019 ◽  
Vol 65 (2) ◽  
pp. 165-171
Author(s):  
Aleksey Belyaev ◽  
Georgiy Prokhorov ◽  
Anna Arkhitskaya

A review of the literature shows that surgical procedures will remain the standard treatment for primary bone tumors. Analysis of studies on the assessment of long-term results shows that additional double cryogenic treatment of the curettage cavity can improve the treatment outcomes of patients with giant cell tumors, dysplastic diseases and some forms of malignant lesions. The traditional execution of the procedure is associated with the open installation of liquid nitrogen in the bone cavity, which requires special skills in handling aggressive refrigerant from the staff and does not exclude complications. In case of multiple metastatic bone lesions, surgical treatment is not indicated. The recent emergence in clinical practice of new equipment with a closed liquid nitrogen circulation circuit inside cryoprobes resumes interest in cryoabla-tion of bone tumor lesions using modern minimally invasive puncture cryotechnology and expanding indications for its use in patients with severe comorbidities.

2016 ◽  
Vol 7 (6) ◽  
pp. 40-42
Author(s):  
Moothiringode Chitrabhanu Savithri ◽  
Kanjirakkad Kavitha ◽  
Dominic Puthoor

Background: Bone lesions are often histologically  heterogenous. The advantage of tru-cut biopsies in this context is that they provide a safe and accurate biopsy technique that can be performed in less specialized centers.  In this series we found combination of biopsy and cytology helpful in diagnosing bone lesions. However clinical picture and radiologic features are vital in arriving at a final diagnosis.Aims and Objective: 1) To assess the diagnostic accuracy of combined CT guided tru-cut biopsy and imprint cytology  in the diagnosis of bone tumors and tumor like lesions. 2)To analyze the spectrum of different bone lesions.Materials and Methods: 108 consecutive cases of bone lesions for which CT guided  tru-cut biopsy and imprint cytology were done between June 2010 and april 2012 were retrospectively studied. Both smears and biopsies were categorized into five groups.Correlation between biopsy and cytology were also evaluated.Results: Total number of cases were 108 of which 8 cases were inconclusive . In 100 cases a useful opinion could be given. There were 36 cases of primary bone tumors, 13 cases of plasma cell neoplasms, 42 metastatic tumors, 9 non neoplastic lesions and 8 inconclusive cases. Conclusion: Preliminary diagnosis of bone lesions before definitive therapy helps to avoid unnecessary surgical procedures. Tru cut biopsies supplemented by imprint cytology can provide definitive diagnosis in majority of cases.Asian Journal of Medical Sciences Vol.7(6) 2016 40-42


1994 ◽  
Vol 84 (8) ◽  
pp. 379-384 ◽  
Author(s):  
MS Dhillon ◽  
B Singh ◽  
DP Singh ◽  
V Prabhu ◽  
ON Nagi

A review of 12 cases of bony tumors involving the talus is presented. Giant cell tumor was the most common tumor. Malignant tumors should be treated by surgical ablation followed by chemotherapy. There are good results after excision or curettage and bone grafting in the treatment of benign neoplasms. Giant cell tumors, if diagnosed early, can be treated by curettage and bone grafting, but if there is talar collapse, a talectomy can be performed.


1981 ◽  
Vol 98 (1) ◽  
pp. 1-6 ◽  
Author(s):  
H. J. Ruckstuhl ◽  
E. Morscher ◽  
W. Remagen ◽  
R. Ganz ◽  
X. Beffa

1982 ◽  
Vol 21 (04) ◽  
pp. 136-139 ◽  
Author(s):  
C.-J. Edeling

Whole-body scintigraphy with both 99mTc-phosphonate and 67Ga was performed on 92 patients suspected of primary bone tumors. In 46 patients with primary malignant bone tumors, scintigraphy with 99mTc-phosphonate disclosed the primary tumor in 44 cases and skeletal metastases in 11, and 67Ga scintigraphy detected the primary tumor in 43 cases, skeletal metastases in 6 cases and soft-tissue metastases in 8 cases. In 25 patients with secondary malignant bone tumors, bone scintigraphy visualized a single lesion in 10 cases and several lesions in 15 cases, and 67Ga scintigraphy detected the primary tumor in 17 cases, skeletal metastases in 17 cases and soft-tissue metastases in 9 cases. In 21 patients with benign bone disease positive uptake of 99mTc-phosphonate was recognized in 19 cases and uptake of 67Ga in 17 cases. It is concluded that bone scintigraphy should be used in patients suspected of primary bone tumors. If malignancy is suspected, 67Ga scintigraphy should be performed in addition.


Author(s):  
Alessandro Luzzati ◽  
Gennaro Maria Scotto ◽  
Luca Cannavò ◽  
Giuseppe Orlando ◽  
Alessandra Scotto di Uccio ◽  
...  

2015 ◽  
Vol 139 (9) ◽  
pp. 1149-1155 ◽  
Author(s):  
Xiaohui Niu ◽  
Hairong Xu ◽  
Carrie Y. Inwards ◽  
Yuan Li ◽  
Yi Ding ◽  
...  

Context Although primary bone tumors are extremely rare, the literature suggests that there are variations in the epidemiologic characteristics in different populations. The most frequently cited epidemiologic characteristics of primary bone tumors are derived from a large US series (Mayo Clinic), with no comparable study thus far performed in China. Objective To identify any potential epidemiologic differences between Chinese patients and a US series of patients. Design We performed a comparison study between 9200 patients treated at Beijing Ji Shui Tan Hospital (JST) and 10 165 patients treated at Mayo Clinic (MC), Rochester Minnesota. Detailed epidemiologic features were analyzed. Results We found that giant cell tumor and osteosarcoma have significantly higher incidences in the JST than the MC patients (P < .001). However, JST patients had a significantly lower incidence of Ewing sarcoma, chordoma, fibrosarcoma, myeloma, and malignant lymphoma (P < .001). For most benign and malignant bone tumors, the Chinese cohort had a more distinct male predominance than the US cohort. Malignant bone tumors had a monomodal age distribution in the JST patient group, with a bimodal age distribution in the MC cohort. Also, there were was a predilection for tumors of the femur and tibia among the JST patients (P < .001). Conclusions Our data confirm that epidemiologic variations of primary bone tumors exist in different populations. Factors that may contribute to these observed differences are proposed and discussed.


1989 ◽  
Vol 38 (2) ◽  
pp. 813-819
Author(s):  
Kensuke Yonemura ◽  
Tatsuaki Tsuchiya ◽  
Takaaki Sagara ◽  
Katsumasa Takagi ◽  
Kimiaki Nishida ◽  
...  

Orthopedics ◽  
1996 ◽  
Vol 19 (12) ◽  
pp. 1011-1016
Author(s):  
Roby C Thompson ◽  
Troy L Berg

Sign in / Sign up

Export Citation Format

Share Document